We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLNT
3376
Fluent
FLNT
$127M
$40K ﹤0.01%
1,833
VOC icon
3377
VOC Energy
VOC
$54.1M
$40K ﹤0.01%
11,213
-3,550
-24% -$16.1K
BAC icon
3378
PUT
Bank of America
BAC
$447B
$39K ﹤0.01%
+40,000
New +$1.09M
FSM icon
3379
Fortuna Silver Mines
FSM
$3.18B
$39K ﹤0.01%
10,663
-10,116
-49% -$37.3K
VTRS icon
3380
PUT
Viatris
VTRS
$18.7B
$39K ﹤0.01%
+20,000
New +$648K
SILV
3381
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$39K ﹤0.01%
+13,184
New +$34K
CLMT icon
3382
Calumet Specialty Products
CLMT
$3.96B
$38K ﹤0.01%
16,999
-10,748
-39% -$44.3K
JOB icon
3383
GEE Group
JOB
$22.1M
$36K ﹤0.01%
50,853
+5,000
+11% +$9.88K
AIG icon
3384
PUT
American International
AIG
$40.7B
$35K ﹤0.01%
+20,000
New +$873K
GSAT icon
3385
Globalstar
GSAT
$10.9B
$35K ﹤0.01%
3,633
+666
+22% +$3.98K
AAPL icon
3386
CALL
Apple
AAPL
$4.5T
$34K ﹤0.01%
255,600
-552,400
-68% -$26.8M
ZYNE
3387
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$34K ﹤0.01%
11,466
-7,200
-39% -$39.4K
EMX
3388
DELISTED
EMX Royalty
EMX
$33K ﹤0.01%
29,449
PDS
3389
Precision Drilling
PDS
$1.05B
$33K ﹤0.01%
947
-50
-5% -$2.48K
DHF
3390
BNY Mellon High Yield Strategies Fund
DHF
$173M
$30K ﹤0.01%
11,088
MPC icon
3391
CALL
Marathon Petroleum
MPC
$90B
$30K ﹤0.01%
136,800
-65,300
-32% -$4.46M
GSV
3392
DELISTED
Gold Standard Ventures Corp.
GSV
$30K ﹤0.01%
24,175
CPRX
3393
DELISTED
Catalyst Pharmaceutical
CPRX
$29K ﹤0.01%
15,007
+2,500
+20% +$7.16K
CVRS
3394
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$29K ﹤0.01%
34,137
DHY
3395
Credit Suisse High Yield Credit Fund
DHY
$243M
$27K ﹤0.01%
12,585
MTVA
3396
MetaVia Inc
MTVA
$7.39M
-1
Closed -$84.1K
AVP
3397
DELISTED
Avon Products, Inc.
AVP
$27K ﹤0.01%
17,617
-200
-1% -$383
UNP icon
3398
CALL
Union Pacific
UNP
$174B
$25K ﹤0.01%
45,300
-33,600
-43% -$4.98M
CSCO icon
3399
CALL
Cisco
CSCO
$483B
$23K ﹤0.01%
+155,000
New +$7.09M
AVEO
3400
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$23K ﹤0.01%
1,430
+410
+40% +$9.02K

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.